High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell
Open Access
- 19 December 2012
- journal article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 14 (3) , 213-221
Abstract
Overexpression of high-mobility group box 2 (HMGB2) is recently reported in several malignant cancers and was correlated with poor response to preoperative chemoradiotherapy of colorectal cancer patients. To enhance the chemoradiotherapy efficacy, the biological function of HMGB2 was investigated with respect to radiation response. HMGB2 gene knockdown cells were constructed by infecting shRNA expressing lentivirus and clonogenic assay was performed to count the radiosensitivity. HMGB2 knockdown sensitized HCT-116 and HT-29 colorectal cancer cells to ionizing radiation. This could be due to an increased DNA damage and an inefficient DNA damage repair in HMGB2 knockdown cells. In addition, an exposure to radiation downregulated HMGB2 expression in colorectal cancer cells with an intact TP53 gene. HMGB2 gene expression of TP53-mutant cell was not affected by irradiation. p53-mediated downregulation of HMGB2 was confirmed by direct activation of p53 using Nutlin-3 or by inducing p53 expression using Tet-On system. Luciferase reporter assay showed that HMGB2 promoter activity was inversely correlated with the amount p53 cotransfected. Our study revealed that HMGB2 is necessary to protect colorectal cancer cells from DNA damage and efficient DNA repair and p53-mediated downregulation is a critical mechanism of modulating HMGB2 expression.Keywords
This publication has 38 references indexed in Scilit:
- High-Mobility Group Boxes Mediate Cell Proliferation and Radiosensitivity via Retinoblastoma-Interaction-Dependent and -Independent MechanismsCancer Biotherapy and Radiopharmaceuticals, 2012
- Quantitative Analysis of the Chromatin Proteome in Disease Reveals Remodeling Principles and Identifies High Mobility Group Protein B2 as a Regulator of Hypertrophic GrowthMolecular & Cellular Proteomics, 2012
- Expression Patterns and Function of Chromatin Protein HMGB2 during Mesenchymal Stem Cell DifferentiationJournal of Biological Chemistry, 2011
- High-mobility group box 1 and cancerBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Chromatin protein HMGB2 regulates articular cartilage surface maintenance via β-catenin pathwayProceedings of the National Academy of Sciences, 2009
- High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma TreatmentMolecular Therapy, 2009
- Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damageMolecular Cancer Therapeutics, 2009
- High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damageProceedings of the National Academy of Sciences, 2008
- HMGB1 Is a Cofactor in Mammalian Base Excision RepairMolecular Cell, 2007
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002